The expanding use of transcatheter valve technologies has changed the landscape in the treatment of valvular disease. Valve surgery is rapidly shifting to more complex scenarios that involve multiple valve interventions and concomitant procedures.
STS leveraged contemporary national data from the STS Adult Cardiac Surgery Database between July 2017 and December 2023 to analyze outcomes of 32,938 patients who underwent multi-valve surgery involving replacement of the aortic valve, plus replacement or repair of the mitral valve, with and without concomitant coronary artery bypass grafting.
When concomitant CABG is required, risks are increased. Mitral replacement increases risk of operative mortality and other adverse outcomes compared to mitral repair. These real-world, contemporary outcomes data are the basis of the new risk calculator.
Questions? Contact the STS Research and Analytic Center.